RSV Hypertonic Saline 3%

For use as diluent for inhalators and nasal hygiene devices.

In Compliance with the 12/2011 professional guideline of the Israeli organizations of infants and children's' health
24 Sterile Single Use Containers of 5mL.
Preservative Free

Acute bronchiolitis is a viral disease usually common in infants and occurs mainly in winter. Treatment of the disease is primarily supportive and based on maintaining hydration and oxygen supplementation when needed.
In recent years, quite a number of studies around the world have proven the effectiveness of treatment with hypertonic saline inhalation in infants, hospitalized due to acute bronchiolitis.

Hypertonic saline inhalation therapy resulted in clinical improvement and shortening of the duration of hospitalization.

Hypertonic saline works by raising fluid lining in the airway walls and reducing the edema layer of the sub-mucosa. It improves rheological properties of sputum and accelerates the mucus clearance (MC).

Recommended use:
  1. For respiratory use with inhalators in cases of bronchiolitis – RSV infections:
    The inhalation of RSV hypertonic saline 3% should be administered in a volume of 4 ml, 3-6 times a day. In light cases, dosage can be reduced to 0-3 ml volume of liquid inhaled. Bronchodilators can be added. Such treatment can be administered at home, in clinics or emergency rooms.
  2. As nasal hygiene: Apply as needed.